The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127102491 12710249 1 I 201608 0 20160901 20160901 DIR FDA-CTU 64.00 YR M N 0.00000 20160831 N PH US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127102491 12710249 1 PS XELODA CAPECITABINE 1 Oral XELODA 1000MG (2 TABS) PO BID FOR 14 DAYS D D X4379X1 20190228 0 1000 MG COATED TABLET BID
127102491 12710249 3 C GABAPENTIN. GABAPENTIN 1 0
127102491 12710249 5 C IMODIUM AD LOPERAMIDE HYDROCHLORIDE 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127102491 12710249 1 Pancreatic carcinoma

Outcome of event

Event ID CASEID OUTC COD
127102491 12710249 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
127102491 12710249 Blood count abnormal
127102491 12710249 Dehydration
127102491 12710249 Diarrhoea

Reporting Sources (this data is often not reported and may therefore be missing here)

Event ID CASEID RPSR COD
127102491 12710249 HP

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
127102491 12710249 1 201603 14 DAY